Treatment Options in Metastatic Castration-Sensitive Prostate Cancer

被引：0
|
作者：
Choudhury, Atish D. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02215 USA
来源：
ONCOLOGY-NEW YORK | 2022年 / 36卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [31] Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health Administration
    Freedland, Stephen J.
    Sandin, Rickard
    Sah, Janvi
    Emir, Birol
    Mu, Qiao
    Ratiu, Anna
    Hong, Agnes
    Serfass, Lucile
    Tagawa, Scott T.
    [J]. CANCER MEDICINE, 2021, 10 (23): : 8570 - 8580
  • [32] Clinical and patient factors associated with treatment intensification for metastatic castration-sensitive prostate cancer.
    Appukkuttan, Sreevalsa
    Williams, Troy
    Jhaveri, Jay
    Campbell, David
    Kong, Sheldon
    Kalayeh, Bashir
    Ramsey, Scott David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 63 - 63
  • [33] APPROACH TO THE TREATMENT OF METASTATIC CASTRATION-SENSITIVE PROSTATE CARCINOMA: A SINGLE CENTER EXPERIENCE
    Semiz, Huseyin Salih
    Keskinkilic, Merve
    Ellez, Halil Ibrahim
    Arayici, Mehmet Emin
    Karaoglu, Aziz
    [J]. JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2022, 6 (01): : 296 - 304
  • [34] The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
    Deek, Matthew P.
    Van der Eecken, Kim
    Phillips, Ryan
    Parikh, Neil R.
    Velho, Pedro Isaacsson
    Lotan, Tamara L.
    Kishan, Amar U.
    Maurer, Tobias
    Boutros, Paul C.
    Hovens, Christopher
    Abramowtiz, Matthew
    Pollack, Alan
    Desai, Neil
    Stish, Bradley
    Feng, Felix Y.
    Eisenberger, Mario
    Carducci, Michael
    Pienta, Kenneth J.
    Markowski, Mark
    Paller, Channing J.
    Antonarakis, Emmanuel S.
    Berlin, Alejandro
    Ost, Piet
    Tran, Phuoc T.
    [J]. EUROPEAN UROLOGY, 2021, 80 (05) : 632 - 640
  • [35] Interstitial Lung Disease Caused by Apalutamide for Metastatic Castration-Sensitive Prostate Cancer
    del Castillo-Acuna, Rocio
    Serradilla, Ana
    Lopez-Campos, Fernando
    Counago, Felipe
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2024, 60 (08): : 537 - 538
  • [36] A cost-utility analysis of apalutamide for metastatic castration-sensitive prostate cancer
    Parmar, Ambica
    Timilshina, Narhari
    Emmenegger, Urban
    Smoragiewicz, Martin
    Sander, Beate
    Alibhai, Shabbir
    Chan, Kelvin K. W.
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2022, 16 (03): : E126 - E131
  • [37] PRESCRIPTION PATTERNS OF SYSTEMIC THERAPY IN THE MANAGEMENT OF METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
    Black, Joseph
    Einstein, David
    Gao, Xin
    Wei, Xiao
    Connell, Brendan
    Kamkari, Nick
    Gershman, Boris
    Olumi, Aria
    [J]. JOURNAL OF UROLOGY, 2023, 209 : E123 - E123
  • [38] Balancing efficacy and financial toxicity in the management of metastatic castration-sensitive prostate cancer
    Sridhar, Srikala S.
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2019, 13 (12): : 404 - 405
  • [39] Treatment patterns of metastatic castration-sensitive prostate cancer (mCSPC): A real-world evidence study
    Tagawa, S. T.
    Sandin, R.
    Sah, J.
    Mu, Q.
    Freedland, S. J.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S541 - S542
  • [40] Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer
    Sutera, P. A.
    Shetty, A. C.
    Hakansson, A.
    Van der Eecken, K.
    Song, Y.
    Liu, Y.
    Chang, J.
    Fonteyne, V.
    Mendes, A. A.
    Lumen, N.
    Delrue, L.
    Verbeke, S.
    De Man, K.
    Rana, Z.
    Hodges, T.
    Hamid, A.
    Roberts, N.
    Song, D. Y.
    Pienta, K.
    Ross, A. E.
    Feng, F.
    Joniau, S.
    Spratt, D.
    Gillessen, S.
    Attard, G.
    James, N. D.
    Lotan, T.
    Davicioni, E.
    Sweeney, C.
    Tran, P. T.
    Deek, M. P.
    Ost, P.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 (07) : 605 - 614
12345